Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Intratumoral combination therapy with poly(I:C) and resiquimod synergistically triggers tumor-associated macrophages for effective systemic antitumoral immunity
Clément Anfray, Francesco Mainini, Elisabeth Digifico, et al.
Journal for ImmunoTherapy of Cancer (2021) Vol. 9, Iss. 9, pp. e002408-e002408
Open Access | Times Cited: 68

Showing 1-25 of 68 citing articles:

Macrophages as tools and targets in cancer therapy
Alberto Mantovani, Paola Allavena, Federica Marchesi, et al.
Nature Reviews Drug Discovery (2022) Vol. 21, Iss. 11, pp. 799-820
Open Access | Times Cited: 1033
pH-gated nanoparticles selectively regulate lysosomal function of tumour-associated macrophages for cancer immunotherapy
Mingmei Tang, Binlong Chen, Heming Xia, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 39
Macrophage polarization in the tumor microenvironment: Emerging roles and therapeutic potentials
Wenru Zhang, Mengmeng Wang, Chonghao Ji, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 177, pp. 116930-116930
Open Access | Times Cited: 16
Tp53 determines the spatial dynamics of M1/M2 tumor-associated macrophages and M1-driven tumoricidal effects
Yi‐Jing Hsiao, Min-Shu Hsieh, Gee‐Chen Chang, et al.
Cell Death and Disease (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 1
The generation, activation, and polarization of monocyte-derived macrophages in human malignancies
Paul Chaintreuil, Emeline Kerreneur, Maxence Bourgoin, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 31
Trial watch: Toll-like receptor ligands in cancer therapy
Julie Le Naour, Guido Kroemer
OncoImmunology (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 26
PTEN Loss Confers Resistance to Anti–PD-1 Therapy in Non–Small Cell Lung Cancer by Increasing Tumor Infiltration of Regulatory T Cells
F. Navarro Expósito, Miriam Redrado, Maeva Houry, et al.
Cancer Research (2023) Vol. 83, Iss. 15, pp. 2513-2526
Open Access | Times Cited: 20
New insights into immune cells in cancer immunotherapy: from epigenetic modification, metabolic modulation to cell communication
Sha Qin, Bin Xie, Qingyi Wang, et al.
MedComm (2024) Vol. 5, Iss. 6
Open Access | Times Cited: 10
Regulating Tumor-Associated Macrophage Polarization by Cyclodextrin-Modified PLGA Nanoparticles Loaded with R848 for Treating Colon Cancer
Haohua Yuan, Huan Gui, Shuanghui Chen, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 3589-3605
Open Access | Times Cited: 9
Polymeric nanocapsules loaded with poly(I:C) and resiquimod to reprogram tumor-associated macrophages for the treatment of solid tumors
Clément Anfray, Carmen Fernández Varela, Aldo Ummarino, et al.
Frontiers in Immunology (2024) Vol. 14
Open Access | Times Cited: 7
Nano-Sized Liposomes for Click-Chemistry-Based Selective Guiding of Immune Cells to Neuroblastoma
Alicia Arroyo-Nogales, Sandra Jiménez-Falcao, Diego Megı́as, et al.
ACS Applied Nano Materials (2025)
Closed Access
Macrophages and cancer stem cells: a malevolent alliance
Paola Allavena, Elisabeth Digifico, Cristina Belgiovine
Molecular Medicine (2021) Vol. 27, Iss. 1
Open Access | Times Cited: 47
Impaired function of dendritic cells within the tumor microenvironment
Zhihua Xiao, Ruiqi Wang, Xuyan Wang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 20
Proteomics and bioinformatics analyses based on two-dimensional electrophoresis and LC-MS/MS for the primary characterization of protein changes in chicken breast meat from divergent farming systems: Organic versus antibiotic-free
Laura Alessandroni, Gianni Sagratini, Mohammed Gagaoua
Food Chemistry Molecular Sciences (2024) Vol. 8, pp. 100194-100194
Open Access | Times Cited: 6
Targeting tumor-associated macrophages to reverse antitumor drug resistance
Li Sheng, Jiyao Sheng, Dan Zhang, et al.
Aging (2024) Vol. 16, Iss. 11, pp. 10165-10196
Open Access | Times Cited: 5
Macrophage diversity in cancer dissemination and metastasis
Alberto Mantovani, Federica Marchesi, Diletta Di Mitri, et al.
Cellular and Molecular Immunology (2024) Vol. 21, Iss. 11, pp. 1201-1214
Open Access | Times Cited: 5
Chitosan/γ-PGA nanoparticles and IFN-γ immunotherapy: A dual approach for triple-negative breast cancer treatment
Flávia Castro, Marta L. Pinto, Catarina Leite Pereira, et al.
Journal of Controlled Release (2025) Vol. 379, pp. 621-635
Open Access
Targeting the Tumor Microenvironment: A Close Up of Tumor-Associated Macrophages and Neutrophils
Massimo Russo, Claudia Nastasi
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 25
Ultrasound improved immune adjuvant delivery to induce DC maturation and T cell activation
Handong Wang, Zhan Shi, Jiali Luo, et al.
Journal of Controlled Release (2022) Vol. 349, pp. 18-31
Closed Access | Times Cited: 24
Emerging advances in nanobiomaterials-assisted chimeric antigen receptor (CAR)-macrophages for tumor immunotherapy
Yanan Zhang, Jingxing Yang, Tinghao Zhang, et al.
Frontiers in Bioengineering and Biotechnology (2023) Vol. 11
Open Access | Times Cited: 13
In situ sprayed hydrogels containing resiquimod-loaded liposomes reduce chronic osteomyelitis recurrence by intracellular bacteria clearance
Liangjie Tian, Zilin Tan, Yusheng Yang, et al.
Acta Biomaterialia (2023) Vol. 169, pp. 209-227
Open Access | Times Cited: 13
Targeting tumor-associated macrophage: an adjuvant strategy for lung cancer therapy
Lei Liu, Genwang Chen, Sisi Gong, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 13
A facile approach to preparing personalized cancer vaccines using iron-based metal organic framework
Xia Li, Shinya Hattori, Mitsuhiro Ebara, et al.
Frontiers in Immunology (2024) Vol. 14
Open Access | Times Cited: 4
Intratumoral immunotherapy using a TLR2/3 agonist, L-pampo, induces robust antitumor immune responses and enhances immune checkpoint blockade
Won Suk Lee, Dong Sung Kim, Jeong Hun Kim, et al.
Journal for ImmunoTherapy of Cancer (2022) Vol. 10, Iss. 6, pp. e004799-e004799
Open Access | Times Cited: 20
Targeting tumor-associated macrophages for the immunotherapy of glioblastoma: Navigating the clinical and translational landscape
Zide Wang, Hanlin Zhong, Xiaohong Liang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 18
Page 1 - Next Page

Scroll to top